https://www.selleckchem.com/pr....oducts/cilengitide-e
17 μm at M24. There were no new safety signals. BCVA variation of ≥6 letters by M3 was predictive of BCVA gains at M24 (p=0.007), as was hypertension medication at baseline (p=0.022). Real-world ranibizumab treatment improved VA in DME patients, despite fewer injections than recommended. Real-world ranibizumab treatment improved VA in DME patients, despite fewer injections than recommended. Oxidative stress may be a risk factor for glaucoma, and many previous reports have suggested that antioxidants could be a
처럼
논평
공유하다
